Zhi Wang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Zhi Wang has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
Chengsan Sun
Department of Psychology, PO Box 400400, University of Virginia, Charlottesville, VA, 22904-4400, United States
1 shared publicationChujie Chen
Department of Urology, Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen, Guangdong Province, China
1 shared publicationDongni Xu
Department of Anesthesiology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong Province, China; Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong Province, China
1 shared publicationHan Yang
Department of Anesthesiology, The First Affiliated Hospital of Shenzhen University, Shenzhen Second People's Hospital, Shenzhen, Guangdong, China
1 shared publicationHuimou Chen
Department of Respiratory Medical Oncology, Cancer Hospital of Shantou University Medical College, Shantou, Guangdong Province, China
1 shared publicationJintao Peng
Reproductive Medicine Research Center, the Sixth Affiliated Hospital of Sun Yat-Sen University, Guangzhou, Guangdong Province, China
1 shared publication
Latest Publications
- 1 August 2019
- Published by Elsevier in Neuroscience Letters
- Vol. 707, 134270
Protective effects of TRPV1 inhibition against sevoflurane-induced cell death
- 1 August 2019
- Published by Elsevier in Neuroscience Letters
- Vol. 707, 134270
Protective effects of TRPV1 inhibition against sevoflurane-induced cell death
- Open Access
- 1 June 2019
- Published by Elsevier in EBioMedicine
- Vol. 44, 403-418
HNF1A inhibition induces the resistance of pancreatic cancer cells to gemcitabine by targeting ABCB1
- 1 June 2019
- Published by Elsevier in EBioMedicine
- Vol. 44, 403-418
Open AccessHNF1A inhibition induces the resistance of pancreatic cancer cells to gemcitabine by targeting ABCB1